The Central Drugs Standard Control Organization (“CDSCO”) has recently released, on their website, a list of drugs, medical devices and cosmetics declared as not of standard /quality /spurious/ adulterated /misbranded, for the month of February, 2019. They include the following:
- Cefpodoxime Oral Suspension I.P. (Monopod)
- Paracetamol Tablets I.P. (Larkin)
- Cefixime & Lactic Acid Bacillus Tablets (Tixi-200 lb)
- Pantoprazole Injection
- Esopen – 20 (Esomeprazole Tablets I.P.)
- Ketorolac Tromethamine Injection I.P. 1 ml
- Leucovorin Calcium Injection I.P
- Ranitac 150 (Ranitidine Hydrochloride Tablets I.P. 150mg)
- Primaquine Tablets IP 7.5 mg (P-quine tablets)
- Aceclofenac, Paracetamol and Serratiopeptidase Tablets (Hifein-sp tablets)
Source: Central Drugs Standard Control Organization